Prolonged QT interval and ventricular fibrillation after treatment with sublingual nifedipine for malignant hypertension.
Peters
F P
FP
de Zwaan
C
C
Kho
L
L
D000286:Administration, Sublingual; D000328:Adult; D002121:Calcium Channel Blockers / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D004562:Electrocardiography; D005260:Female; D006329:Heart Conduction System / Q000187:drug effects*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D009543:Nifedipine / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D014693:Ventricular Fibrillation / Q000139:chemically induced*
D002121:Calcium Channel Blockers; D009543:Nifedipine